Nursing Home Antibiotic Use Linked to High Rate of Problems: Study

Antibiotics are frequently prescribed to many nursing home residents. However, new research suggests that the drugs may be contributing to potentially serious health problems, including gastroenteritis, Clostridium difficile and antibiotic resistant bacteria. 

Researchers from the University of Toronto found one in eight nursing home residents experienced an adverse event related to antibiotic use, regardless of whether they were taking the antibiotics themselves. The findings were published June 29, in the journal JAMA Internal Medicine.

The longitudinal open-cohort study focused on more than 110,000 older adults in 607 different nursing homes in Ontario, Canada, between January 1, 2010, through December 31, 2011.

Did You Know?

Ticketmaster Data Breach Impacts Millions of Customers

A massive Ticketmaster data breach exposed the names, addresses, phone numbers, credit card numbers and other personal information of more than 560 million customers, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Researchers found that six percent to 10% of nursing home residents are taking antibiotics at any given time and more than half of them receive at least one antibiotic prescription each year.

Nursing home residents in the highest third of antibiotic use facilities had a 24% higher risk of having antibiotic related adverse events compared to those in the lower two-thirds of the facilities.

Antibiotic related adverse events were found to be more common in residents of high use homes at 13.3%, than among residents of medium use at 12.4% or low use homes 11.4%. The overuse contributes to adverse events, including contributing to the development of superbugs.

Overall researchers found residents were on antibiotics for an average of 20 to 192 days per 1,000 resident days.

Researchers found that high-use nursing homes were linked to an increased risk of residents experiencing antibiotic related adverse events, even residents who did not receive antibiotic treatments experience events.

Antibiotic-related adverse events included Clostridium difficile (C. diff), diarrhea, gastroenteritis, allergic reactions, general medication adverse events and antibiotic-resistant bacteria or superbugs.

The C. diff findings appear to confirm a study published in February, which revealed that the majority of the nearly half a million C. diff infections in the U.S. are hospital acquired infections among older patients taking antibiotics.

C. diff is the most common hospital-acquired infection in the U.S., striking particularly hard at patients ages 65 and older. The infections can cause fatal cases of colon inflammation and diarrhea.

“Residents of high-use homes are exposed to an increased risk of antibiotic-related harms even if they have not directly received these agents,” wrote study authors. “Antibiotic stewardship is needed to improve the safety of all nursing home residents.”

The study comes amid increasing concerns over antibiotic use.

A British Government report released last year warned there would be 10 million deaths each year by 2050 attributable to antibiotic resistant infections unless steps are taken to mitigate the growing risks posed by the overuse of antibiotic drugs.

Earlier this year, drug-resistant superbugs recently made headlines across the country after nearly 200 patients treated at California’s UCLA Medical Center were exposed to a deadly antibiotic-resistant bacteria. The outbreak caused two deaths, seven confirmed infections and was linked to tainted medical equipment, which had undergone normal sterilization treatment.

The U.S. Centers for Disease Control and Prevention (CDC) estimates drug-resistant bacteria, or superbugs, cause 2 million illnesses and approximately 23,000 deaths each year in the United States alone.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Ozempic MDL Court To Evaluate Need for Gastroparesis Diagnostic Testing in GLP-1 Lawsuits
Ozempic MDL Court To Evaluate Need for Gastroparesis Diagnostic Testing in GLP-1 Lawsuits (Posted 2 days ago)

A federal judge has agreed to divide lawsuits over gastroparesis injuries linked to drugs like Ozempic and Mounjaro into multiple phases, examining how the condition is diagnosed and whether plaintiffs' claims are preempted by federal laws.

Adult Woman Files Similac Lawsuit Over NEC Injuries Experienced as a Newborn
Adult Woman Files Similac Lawsuit Over NEC Injuries Experienced as a Newborn (Posted 3 days ago)

Lawsuit alleges that Abbott Laboratories failed to provide families and the medical community with adequate warnings about the risks associated with it’s cow’s milk-based Similac formula, which a now adult woman indicates has left her with life-long NEC injuries.

Amended Lawsuit Over BioZorb Implant Side Effects Outlines Problems Caused By Tissue Marker Design Defects
Amended Lawsuit Over BioZorb Implant Side Effects Outlines Problems Caused By Tissue Marker Design Defects (Posted 4 days ago)

Six breast cancer patients have asked a federal judge for permission to amend a complaint filed in March 2024, which describes problems linked to the device and painful side effects experienced when the tissue marker migrated out of position or shattered inside their bodies.